Levetiracetam 500mg, 750mg; ext-rel tabs. Swallow whole. ≥12yrs (≥50kg): initially 1g once daily; may increase at 2-week intervals in increments of 1g/day; max 3g/day. Renal impairment: CrCl ...
Levetiracetam 100mg/mL; IV infusion after dilution. Infuse over 15mins. Partial onset: ≥16yrs: initially 500mg twice daily; may increase at 2-week intervals in increments of 1g/day; max 3g/day ...
GlobalData on MSN9d
CBC acquires UCB’s neurology and allergy business in ChinaCBC Group, in partnership with the Mubadala Investment Company, has completed the strategic acquisition of Union Chimique ...
It's not wholly new however as some established drugs, namely UCB's Keppra (levetiracetam) and Briviact (brivaracetam), bind to SV2A and inhibit its activity as a way to treat epilepsy.
The $680m deal includes UCB's brands Keppra, Vimpat, Neupro, Zyrtec, Xyzal, and its Zhuhai manufacturing site, and was made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback